Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus
Xufen Zeng, Krista A Varady, Xiangdong Wang, et al.
Metabolism (2024) Vol. 161, pp. 156028-156028
Closed Access | Times Cited: 18
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 17
An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
Le Zhang, Mortada El‐Shabrawi, Louise A. Baur, et al.
Med (2024) Vol. 5, Iss. 7, pp. 797-815.e2
Closed Access | Times Cited: 16
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Xiaodong Zhou, Seung Up Kim, Terry Cheuk‐Fung Yip, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1883-1892
Closed Access | Times Cited: 15
Association between metabolic dysfunction associated steatotic liver disease and gallstones in the US population using propensity score matching
Yingying Zhang, Jingjing Zhang, Dan Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021
Chunlong Liu, Ziqiang He, Jiangtao Yu, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Editorial: Hyperferritinaemia—An Ironclad Biomarker for the Prognostication of MASLD?
Mark Chang-Chuen Cheah, Chee‐Kiat Tan
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease
Ziyan Pan, Moutaz Derbala, Khalid Al‐Naamani, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101512-101512
Open Access | Times Cited: 13
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Resmetirom for MASH patients with diabetes: challenges and opportunities in the real world
Li-You Lian, Giovanni Targher, Christopher D. Byrne, et al.
Metabolism (2024) Vol. 156, pp. 155935-155935
Closed Access | Times Cited: 11
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Huai Zhang, Giovanni Targher, Christopher D. Byrne, et al.
Hepatology International (2024) Vol. 18, Iss. 4, pp. 1178-1201
Closed Access | Times Cited: 11
Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives
Xiaopeng Li, Enjun Xie, Shumin Sun, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Thyromimetics and MASLD: Unveiling the Novel Molecules Beyond Resmetirom
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study
Xiaodong Zhou, Cuifang Xu, Qin‐Fen Chen, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3684-3695
Closed Access | Times Cited: 6
Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018
Weijie Liu, Xiulin Yang, Ting Zhan, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma
Ohad Etzion, Avital Bareket‐Samish, David Yardeni, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 848-848
Open Access | Times Cited: 5
Association of MASLD with the risk of extrahepatic cancers: A systematic review and meta‐analysis of 18 cohort studies
Ben‐Gang Zhou, Xin Jiang, Qiang She, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Closed Access | Times Cited: 5
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation
Wenhui Liu, Danming You, Jiayang Lin, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2245-2261.e6
Closed Access | Times Cited: 5
Exploring Molecular Mechanisms of Liver Fibrosis
Ralf Weiskirchen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 326-326
Open Access
Insulin resistance as a mediator in the association between nickel exposure and metabolic dysfunction-associated steatotic liver disease
Zhou Liu, Liang Zhang, Yanrui Wu, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Correlation between family function and self-management abilities in patients with metabolic dysfunction-associated steatotic liver disease
Yueying Zhu, Ru Chen, Hang Han, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
The Impact of Incidental Hepatocellular Carcinoma in Liver Transplantation: A Growing Concern
Alfredo Caturano, Enes Erul
Clinics and Research in Hepatology and Gastroenterology (2025) Vol. 49, Iss. 3, pp. 102550-102550
Closed Access
Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care
Nicola Pugliese, Arianna Bertazzoni, Cesare Hassan, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 722-722
Open Access
Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study
Jong-Hee Lee, Ha Eun Ryu, Taehwa Han, et al.
Endocrine (2025)
Closed Access
Therapeutic Potential of GLP-1 Receptor Agonists in Metabolic Associated Steatotic Liver Disease
Klaudia Nowak, Krzysztof Łupina, Anna Romac, et al.
Annals of Pharmacotherapy (2025)
Closed Access
Page 1 - Next Page

Scroll to top